ask="3.25"
ask_size="800"
average_daily_volume="3677580"
bid="3.21"
bid_size="2100"
book_value="-1.93"
change="+0.13"
change_from_200_day_moving_average="-1.43"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-5.79"
change_From_52_week_low="0.40"
change_in_percent="+4.19%"
close="3.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.21"
ebitda="-95.24M"
eps_estimate_current_year="-0.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.58"
ex_dividend_date="N/A"
float_shares="105666000"
high="3.28"
high_52_weeks="9.02"
last_trade_date="3/6/2017"
last_trade_price="3.23"
last_trade_size="33197"
last_trade_time="4:00pm"
low="3.06"
low_52_weeks="2.83"
market_capitalization="421.74M"
moving_average_200_day="4.66"
moving_average_50_day="3.11"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.10"
pe_ratio="N/A"
peg_ratio="-1.21"
percent_change_from_200_day_moving_average="-30.67%"
percent_change_from_50_day_moving_average="+3.86%"
percent_change_from_52_week_high="-64.17%"
percent_change_from_52_week_low="+14.13%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="2.81"
revenue="144.27M"
shares_outstanding="130570000"
short_ratio="10.15"
stock_exchange="NGM"
symbol="MACK"
volume="2357991"
weeks_range_52="2.83 - 9.02"
